Study of Enahnced External Counterpulsation to Treat Coronary Heart Disease

• Status: Unknown status
• Trial end date: 2013-09-01
• Target enrollment: 0
• Participant gender: All

Summary

To investigate the mid- and long-term effect of Enhanced External Counterpulsation combined with guideline-driven standard treatment on patients documented with and/or at high risk of coronary artery disease.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sun Yat-sen University

Criteria

Inclusion Criteria:

• at least one coronary lesion of more than 50% stenosis shown by angiography

• history of acute myocardial infarction(at least one month before)

• history of prior revascularization (Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting)

• typical angina episodes with evidence of myocardial ischemia

• Signed informed consent

Exclusion Criteria:

• Obvious aortic insufficiency, aortic aneurysm, aortic dissection

• Coronary fistula or severe coronary aneurysm

• Symptomatic Congestive heart failure

• Valvular heart disease, congenital heart diseases, cardiomyopathies

• Cerebral hemorrhage within six months, bleeding disorders or identified bleeding tendency;

• Lower limb infection, phlebitis, varicosity, deep venous thrombosis;

• Progressive malignancies or diseases with poor prognosis;

• uncontrolled hypertension, defined as SBP≥180mmHg or DBP≥110mmHg